Literature DB >> 11233998

Resveratrol decreases hyperalgesia induced by carrageenan in the rat hind paw.

M Gentilli1, J X Mazoit, H Bouaziz, D Fletcher, R F Casper, D Benhamou, J F Savouret.   

Abstract

The effect of resveratrol, an aryl hydrocarbon receptor (AhR) antagonist, known to inhibit inducible cyclooxygenase-2 (COX2) and its transcription were examined in a model of hyperalgesia induced by carrageenan in the rat. Pretreatment with resveratrol did not reverse swelling and edema, but reversed the hyperalgesia induced by local tissue injury provoked by carrageenan. This reversal, occurring at resveratrol concentrations as low as 2 mg/kg, lasted for at least 48 hours. The link with COX2 activity inhibition and COX2 gene transcription, as well as a potential AhR inhibitory effect, remain to be established.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11233998     DOI: 10.1016/s0024-3205(00)01018-3

Source DB:  PubMed          Journal:  Life Sci        ISSN: 0024-3205            Impact factor:   5.037


  16 in total

Review 1.  AMPK: An emerging target for modification of injury-induced pain plasticity.

Authors:  Theodore J Price; Gregory Dussor
Journal:  Neurosci Lett       Date:  2013-07-03       Impact factor: 3.046

2.  Improvement of Resveratrol Effects When Combined with Rice Oil in Rat Models of Inflammation.

Authors:  Rodrigo B M Silva; Izaque S Maciel; Alice Ribeiro; Gabriel Rübensam; Andressa Bernardi; Fernanda B Morrone; Andre A Souto; Maria M Campos
Journal:  Inflammation       Date:  2020-02       Impact factor: 4.092

Review 3.  Molecular bases of caloric restriction regulation of neuronal synaptic plasticity.

Authors:  Angela Fontán-Lozano; Guillermo López-Lluch; José María Delgado-García; Placido Navas; Angel Manuel Carrión
Journal:  Mol Neurobiol       Date:  2008-08-30       Impact factor: 5.590

4.  Resveratrol: French paradox revisited.

Authors:  Betul Catalgol; Saime Batirel; Yavuz Taga; Nesrin Kartal Ozer
Journal:  Front Pharmacol       Date:  2012-07-17       Impact factor: 5.810

5.  Modulation of TRP channels by resveratrol and other stilbenoids.

Authors:  Lina Yu; Shenglan Wang; Yoko Kogure; Satoshi Yamamoto; Koichi Noguchi; Yi Dai
Journal:  Mol Pain       Date:  2013-02-15       Impact factor: 3.395

6.  A review on chemical and biological properties of Cayratia trifolia Linn. (Vitaceae).

Authors:  Dinesh Kumar; Sunil Kumar; Jyoti Gupta; Renu Arya; Ankit Gupta
Journal:  Pharmacogn Rev       Date:  2011-07

7.  Resveratrol engages AMPK to attenuate ERK and mTOR signaling in sensory neurons and inhibits incision-induced acute and chronic pain.

Authors:  Dipti V Tillu; Ohannes K Melemedjian; Marina N Asiedu; Ning Qu; Milena De Felice; Gregory Dussor; Theodore J Price
Journal:  Mol Pain       Date:  2012-01-23       Impact factor: 3.395

8.  Resveratrol inhibits Cdk5 activity through regulation of p35 expression.

Authors:  Elias Utreras; Anita Terse; Jason Keller; Michael J Iadarola; Ashok B Kulkarni
Journal:  Mol Pain       Date:  2011-07-07       Impact factor: 3.395

Review 9.  Metabolic engineering of yeast and plants for the production of the biologically active hydroxystilbene, resveratrol.

Authors:  Philippe Jeandet; Bertrand Delaunois; Aziz Aziz; David Donnez; Yann Vasserot; Sylvain Cordelier; Eric Courot
Journal:  J Biomed Biotechnol       Date:  2012-05-13

10.  Resveratrol has protective effects against airway remodeling and airway hyperreactivity in a murine model of allergic airways disease.

Authors:  Simon G Royce; William Dang; Gao Yuan; Jenny Tran; Assam El Osta; Tom C Karagiannis; Mimi L K Tang
Journal:  Pathobiol Aging Age Relat Dis       Date:  2011-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.